FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:718-724 September 2, 1999 Number 10 Next

	Full Text PDF Editorial by Tavill, A. S. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background and Methods Hereditary hemochromatosis is associated with homozygosity for the C282Y mutation in the hemochromatosis (HFE) gene on chromosome 6, elevated serum transferrin saturation, and excess iron deposits throughout the body. To assess the prevalence and clinical expression of the HFE gene, we conducted a population-based study in Busselton, Australia. In 1994, we obtained blood samples for the determination of serum transferrin saturation and ferritin levels and the presence or absence of the C282Y mutation and the H63D mutation (which may contribute to increased hepatic iron levels) in 3011 unrelated white adults. We evaluated all subjects who had persistently elevated transferrin-saturation values (45 percent or higher) or were homozygous for the C282Y mutation. We recommended liver biopsy for subjects with serum ferritin levels of 300 ng per milliliter or higher. The subjects were followed for up to four years.

Results Sixteen of the subjects (0.5 percent) were homozygous for the C282Y mutation, and 424 (14.1 percent) were heterozygous. The serum transferrin saturation was 45 percent or higher in 15 of the 16 who were homozygous; in 1 subject it was 43 percent. Four of the homozygous subjects had previously been given a diagnosis of hemochromatosis, and 12 had not. Seven of these 12 patients had elevated serum ferritin levels in 1994; 6 of the 7 had further increases in 1998, and 1 had a decrease, although the value remained elevated. The serum ferritin levels in the four other homozygous patients remained in the normal range. Eleven of the 16 homozygous subjects underwent liver biopsy; 3 had hepatic fibrosis, and 1, who had a history of excessive alcohol consumption, had cirrhosis and mild microvesicular steatosis. Eight of the 16 homozygous subjects had clinical findings that were consistent with the presence of hereditary hemochromatosis, such as hepatomegaly, skin pigmentation, and arthritis.

Conclusions In a population of white adults of northern European ancestry, 0.5 percent were homozygous for the C282Y mutation in the HFE gene. However, only half of those who were homozygous had clinical features of hemochromatosis, and one quarter had serum ferritin levels that remained normal over a four-year period.

Source Information

From the Department of Medicine, University of Western Australia, Fremantle (J.K.O.); the Department of Gastroenterology, Fremantle Hospital, Fremantle (J.K.O., D.J.C., S.A.); the Busselton Population Medical Research Foundation, Perth (D.J.C.); the Pathcentre, Queen Elizabeth II Medical Centre, Nedlands (E.R.); and the Queensland Institute of Medical Research and the University of Queensland, Brisbane (L.S., L.W.P.) — all in Australia.

Address reprint requests to Dr. Olynyk at the University Department of Medicine, P.O. Box 480, Fremantle 6959, Western Australia, Australia, or at jolynyk{at}cyllene.uwa.edu.au.

Full Text of this Article

This article has been cited by other articles:

• Solanas-Barca, M., Mateo-Gallego, R., Calmarza, P., Jarauta, E., Bea, A. M., Cenarro, A., Civeira, F. (2009). Mutations in HFE Causing Hemochromatosis Are Associated with Primary Hypertriglyceridemia. J. Clin. Endocrinol. Metab. 94: 4391-4397 [Abstract] [Full Text]  
• Rogowski, W. H. (2009). The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study. Med Decis Making 29: 224-238 [Abstract]  
• McLaren, G. D., Gordeuk, V. R. (2009). Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. ASH Education Book 2009: 195-206 [Abstract] [Full Text]  
• Ajioka, R. S., Phillips, J. D., Weiss, R. B., Dunn, D. M., Smit, M. W., Proll, S. C., Katze, M. G., Kushner, J. P. (2008). Down-regulation of hepcidin in porphyria cutanea tarda. Blood 112: 4723-4728 [Abstract] [Full Text]  
• Nagayoshi, Y., Nakayama, M., Suzuki, S., Hokamaki, J., Shimomura, H., Tsujita, K., Fukuda, M., Yamashita, T., Nakamura, Y., Sugiyama, S., Ogawa, H. (2008). A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis. Eur J Heart Fail 10: 1001-1006 [Abstract] [Full Text]  
• Davis, T. M.E., Beilby, J., Davis, W. A., Olynyk, J. K., Jeffrey, G. P., Rossi, E., Boyder, C., Bruce, D. G. (2008). Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study. Diabetes Care 31: 1795-1801 [Abstract] [Full Text]  
• Cooper, K., Bryant, J., Picot, J., Clegg, A., Roderick, P.R., Rosenberg, W.M., Patch, C. (2008). A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations. QJM 101: 631-641 [Abstract] [Full Text]  
• Milward, E. A., Baines, S. K., Knuiman, M. W., Bartholomew, H. C., Divitini, M. L., Ravine, D. G., Bruce, D. G., Olynyk, J. K. (2008). Noncitrus Fruits as Novel Dietary Environmental Modifiers of Iron Stores in People With or Without HFE Gene Mutations. Mayo Clin Proc. 83: 543-549 [Abstract] [Full Text]  
• Wood, M. J., Powell, L. W., Ramm, G. A. (2008). Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 111: 4456-4462 [Abstract] [Full Text]  
• Allen, K. J., Gurrin, L. C., Constantine, C. C., Osborne, N. J., Delatycki, M. B., Nicoll, A. J., McLaren, C. E., Bahlo, M., Nisselle, A. E., Vulpe, C. D., Anderson, G. J., Southey, M. C., Giles, G. G., English, D. R., Hopper, J. L., Olynyk, J. K., Powell, L. W., Gertig, D. M. (2008). Iron-Overload-Related Disease in HFE Hereditary Hemochromatosis. NEJM 358: 221-230 [Abstract] [Full Text]  
• Bacon, B. R., Britton, R. S. (2008). Clinical Penetrance of Hereditary Hemochromatosis. NEJM 358: 291-292 [Full Text]  
• Piperno, A., Girelli, D., Nemeth, E., Trombini, P., Bozzini, C., Poggiali, E., Phung, Y., Ganz, T., Camaschella, C. (2007). Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110: 4096-4100 [Abstract] [Full Text]  
• (2007). Brown and Black Scaly Patches on the Lower Leg Diagnosis. Arch Dermatol 143: 1441-1446 [Full Text]  
• Alizadeh, B Z, Njajou, O T, Hazes, J M W, Hofman, A, Slagboom, P E, Pols, H A P, van Duijn, C M (2007). The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis. Ann Rheum Dis 66: 1436-1442 [Abstract] [Full Text]  
• Thursz, M. (2007). Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection. Gut 56: 613-614 [Full Text]  
• McCullough, K. D., Bartfay, W. J. (2007). The Dose-Dependent Effects of Chronic Iron Overload on the Production of Oxygen Free Radicals and Vitamin E Concentrations in the Liver of a Murine Model. Biol Res Nurs 8: 300-304 [Abstract]  
• Sutedja, N. A., Sinke, R. J., Van Vught, P. W. J., Van der Linden, M. W., Wokke, J. H. J., Van Duijn, C. M., Njajou, O. T., Van der Schouw, Y. T., Veldink, J. H., Van den Berg, L. H. (2007). The Association Between H63D Mutations in HFE and Amyotrophic Lateral Sclerosis in a Dutch Population. Arch Neurol 64: 63-67 [Abstract] [Full Text]  
• Ma, A. D., Udden, M. M. (2007). Iron metabolism, iron overload, and the porphyrias. ASH-SAP 2007: 61-77 [Full Text]  
• Chung, R. T., Misdraji, J., Sahani, D. V. (2006). Case 33-2006 -- A 43-Year-Old Man with Diabetes, Hypogonadism, Cirrhosis, Arthralgias, and Fatigue. NEJM 355: 1812-1819 [Full Text]  
• Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L., Smith, P. R. (2006). Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.. ANN INTERN MED 145: 209-223 [Abstract] [Full Text]  
• Krayenbuehl, P.-A., Maly, F. E., Hersberger, M., Wiesli, P., Himmelmann, A., Eid, K., Greminger, P., Vetter, W., Schulthess, G. (2006). Tumor Necrosis Factor-{alpha} -308G>A Allelic Variant Modulates Iron Accumulation in Patients with Hereditary Hemochromatosis. Clin. Chem. 52: 1552-1558 [Abstract] [Full Text]  
• Vantyghem, M.-C., Fajardy, I., Dhondt, F., Girardot, C., D'Herbomez, M., Danze, P.-M., Rousseaux, J., Wemeau, J.-L. (2006). Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department.. Eur J Endocrinol 154: 835-841 [Abstract] [Full Text]  
• Lecube, A., Hernandez, C., Genesca, J., Simo, R. (2006). Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients: A case-control study. Diabetes Care 29: 1096-1101 [Abstract] [Full Text]  
• Powell, L. W., Dixon, J. L., Ramm, G. A., Purdie, D. M., Lincoln, D. J., Anderson, G. J., Subramaniam, V. N., Hewett, D. G., Searle, J. W., Fletcher, L. M., Crawford, D. H., Rodgers, H., Allen, K. J., Cavanaugh, J. A., Bassett, M. L. (2006). Screening for hemochromatosis in asymptomatic subjects with or without a family history.. Arch Intern Med 166: 294-301 [Abstract] [Full Text]  
• Goland, S., Malnick, S. D., Ellervik, C., Nordestgaard, B. G., Tybjaerg-Hansen, A., Grande, P., Tybjaerg-Hansen, A., Appleyard, M., Nordestgaard, B. G. (2006). Letter Regarding Article by Ellervik et al, "Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study" * Response. Circulation 113: e10-e10 [Full Text]  
• Camaschella, C. (2005). Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106: 3710-3717 [Abstract] [Full Text]  
• Qaseem, A., Aronson, M., Fitterman, N., Snow, V., Weiss, K. B., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee, (2005). Screening for Hereditary Hemochromatosis: A Clinical Practice Guideline from the American College of Physicians. ANN INTERN MED 143: 517-521 [Abstract] [Full Text]  
• Schmitt, B., Golub, R. M., Green, R. (2005). Screening Primary Care Patients for Hereditary Hemochromatosis with Transferrin Saturation and Serum Ferritin Level: Systematic Review for the American College of Physicians. ANN INTERN MED 143: 522-536 [Abstract] [Full Text]  
• Stickel, F., Osterreicher, C. H., Datz, C., Ferenci, P., Wolfel, M., Norgauer, W., Kraus, M. R., Wrba, F., Hellerbrand, C., Schuppan, D. (2005). Prediction of Progression to Cirrhosis by a Glutathione S-Transferase P1 Polymorphism in Subjects With Hereditary Hemochromatosis. Arch Intern Med 165: 1835-1840 [Abstract] [Full Text]  
• Chan, A. T., Ma, J., Tranah, G. J., Giovannucci, E. L., Rifai, N., Hunter, D. J., Fuchs, C. S. (2005). Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women. JNCI J Natl Cancer Inst 97: 917-926 [Abstract] [Full Text]  
• Robinson, J. P., Johnson, V. L., Rogers, P. A., Houlston, R. S., Maher, E. R., Bishop, D.T., Evans, D.G. R., Thomas, H. J.W., Tomlinson, I. P.M., Silver, A. R.J., Colorectal Cancer Gene Identification (CORGI) cons, (2005). Evidence for an Association between Compound Heterozygosity for Germ Line Mutations in the Hemochromatosis (HFE) Gene and Increased Risk of Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev. 14: 1460-1463 [Abstract] [Full Text]  
• Krayenbuehl, P.-A., Walczyk, T., Schoenberg, R., von Blanckenburg, F., Schulthess, G. (2005). Hereditary hemochromatosis is reflected in the iron isotope composition of blood. Blood 105: 3812-3816 [Abstract] [Full Text]  
• Cadet, E, Capron, D, Gallet, M, Omanga-Leke, M-L, Boutignon, H, Julier, C, Robson, K J H, Rochette, J (2005). Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?. J. Med. Genet. 42: 390-395 [Abstract] [Full Text]  
• Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., Dawkins, F. W., Acton, R. T., Harris, E. L., Gordeuk, V. R., Leiendecker-Foster, C., Speechley, M., Snively, B. M., Holup, J. L., Thomson, E., Sholinsky, P., the Hemochromatosis and Iron Overload Screening (H, (2005). Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. NEJM 352: 1769-1778 [Abstract] [Full Text]  
• Valenti, L, Conte, D, Piperno, A, Dongiovanni, P, Fracanzani, A L, Fraquelli, M, Vergani, A, Gianni, C, Carmagnola, L, Fargion, S (2004). The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J. Med. Genet. 41: 946-950 [Abstract] [Full Text]  
• Lecube, A., Hernandez, C., Genesca, J., Esteban, J. I., Jardi, R., Garcia, L., Simo, R. (2004). Diabetes Is the Main Factor Accounting for the High Ferritin Levels Detected in Chronic Hepatitis C Virus Infection. Diabetes Care 27: 2669-2675 [Abstract] [Full Text]  
• Hunt, J. R, Zeng, H. (2004). Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am. J. Clin. Nutr. 80: 924-931 [Abstract] [Full Text]  
• Palka, P., Lange, A., Atherton, J., Stafford, W. J., Burstow, D. J. (2004). Biventricular diastolic behaviour in patients with hypertrophic and hereditary hemochromatosis cardiomyopathies. Eur J Echocardiogr 5: 356-366 [Abstract] [Full Text]  
• Chua, A. C. G., Olynyk, J. K., Leedman, P. J., Trinder, D. (2004). Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis. Blood 104: 1519-1525 [Abstract] [Full Text]  
• Davis, M. T., Bartfay, W. J. (2004). Ebselen Decreases Oxygen Free Radical Production and Iron Concentrations in the Hearts of Chronically Iron-Overloaded Mice. Biol Res Nurs 6: 37-45 [Abstract]  
• Pietrangelo, A. (2004). Hereditary Hemochromatosis -- A New Look at an Old Disease. NEJM 350: 2383-2397 [Full Text]  
• Limdi, J.K., Crampton, J.R. (2004). Hereditary haemochromatosis. QJM 97: 315-324 [Abstract] [Full Text]  
• Lanzara, C., Roetto, A., Daraio, F., Rivard, S., Ficarella, R., Simard, H., Cox, T. M., Cazzola, M., Piperno, A., Gimenez-Roqueplo, A.-P., Grammatico, P., Volinia, S., Gasparini, P., Camaschella, C. (2004). Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103: 4317-4321 [Abstract] [Full Text]  
• Andersen, R. V., Tybjaerg-Hansen, A., Appleyard, M., Birgens, H., Nordestgaard, B. G. (2004). Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103: 2914-2919 [Abstract] [Full Text]  
• Miranda, C. J., Makui, H., Andrews, N. C., Santos, M. M. (2004). Contributions of {beta}2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1-/- and {beta}2mRag1-/- double knock-out mice. Blood 103: 2847-2849 [Abstract] [Full Text]  
• Olynyk, J. K., Hagan, S. E., Cullen, D. J., Beilby, J., Whittall, D. E. (2004). Evolution of Untreated Hereditary Hemochromatosis in the Busselton Population: A 17-Year Study. Mayo Clin Proc. 79: 309-313 [Abstract]  
• McDonnell, S. M., Parrish, R. G. (2003). Hereditary Hemochromatosis and Its Elusive Natural History. Arch Intern Med 163: 2421-2423 [Full Text]  
• Dubois, S., Kowdley, K. V. (2003). The Importance of Screening for Hemochromatosis. Arch Intern Med 163: 2424-2426 [Full Text]  
• Scotet, V., Merour, M.-C., Mercier, A.-Y., Chanu, B., Le Faou, T., Raguenes, O., Le Gac, G., Mura, C., Nousbaum, J.-B., Ferec, C. (2003). Hereditary Hemochromatosis: Effect of Excessive Alcohol Consumption on Disease Expression in Patients Homozygous for the C282Y Mutation. Am J Epidemiol 158: 129-134 [Abstract] [Full Text]  
• Stuart, K A, Anderson, G J, Frazer, D M, Powell, L W, McCullen, M, Fletcher, L M, Crawford, D H G (2003). Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut 52: 953-959 [Abstract] [Full Text]  
• Fruchon, S., Bensaid, M., Borot, N., Roth, M.-P., Coppin, H. (2003). Use of Denaturing HPLC and a Heteroduplex Generator to Detect the HFE C282Y Mutation Associated with Genetic Hemochromatosis. Clin. Chem. 49: 822-824 [Full Text]  
• Surber, R, Sigusch, H H, Kuehnert, H, Figulla, H R (2003). Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography. J. Med. Genet. 40: e58-58 [Full Text]  
• Ferenci, P (2003). How to identify the genetic basis of gastrointestinal and liver diseases?. Gut 52: ii6-9 [Abstract] [Full Text]  
• Pietrangelo, A (2003). Haemochromatosis. Gut 52: ii23-30 [Abstract] [Full Text]  
• Beutler, E. (2003). The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 101: 3347-3350 [Full Text]  
• Ajioka, R. S., Kushner, J. P. (2003). Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 101: 3351-3353 [Full Text]  
• Beutler, E. (2003). Rebuttal to Ajioka and Kushner. Blood 101: 3354-3357 [Full Text]  
• Shaheen, N. J., Silverman, L. M., Keku, T., Lawrence, L. B., Rohlfs, E. M., Martin, C. F., Galanko, J., Sandler, R. S. (2003). Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer. JNCI J Natl Cancer Inst 95: 154-159 [Abstract] [Full Text]  
• Beutler, E., Hoffbrand, A. V., Cook, J. D. (2003). Iron Deficiency and Overload. ASH Education Book 2003: 40-61 [Abstract] [Full Text]  
• Ramakrishnan, U., Kuklina, E., Stein, A. D (2002). Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am. J. Clin. Nutr. 76: 1256-1260 [Abstract] [Full Text]  
• Holmstrom, P, Marmur, J, Eggertsen, G, Gafvels, M, Stal, P (2002). Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51: 723-730 [Abstract] [Full Text]  
• Trinder, D, Fox, C, Vautier, G, Olynyk, J K (2002). Molecular pathogenesis of iron overload. Gut 51: 290-295 [Abstract] [Full Text]  
• Timms, A E, Sathananthan, R, Bradbury, L, Athanasou, N A, Brown, M A (2002). Genetic testing for haemochromatosis in patients with chondrocalcinosis. Ann Rheum Dis 61: 745-747 [Abstract] [Full Text]  
• Waalen, J., Felitti, V., Gelbart, T., Ho, N. J., Beutler, E. (2002). Prevalence of Hemochromatosis-Related Symptoms Among Individuals With Mutations in the HFE Gene. Mayo Clin Proc. 77: 522-530 [Abstract]  
• Stovner, L., Hagen, K, Waage, A, Bjerve, K. (2002). Hereditary Haemochromatosis in Two Cousins with Cluster Headache. Cephalalgia 22: 317-319 [Abstract] [Full Text]  
• Trinder, D., Olynyk, J. K., Sly, W. S., Morgan, E. H. (2002). Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc. Natl. Acad. Sci. USA 99: 5622-5626 [Abstract] [Full Text]  
• Willis, G., Scott, D. G. I., Jennings, B. A., Smith, K., Bukhari, M., Wimperis, J. Z. (2002). HFE mutations in an inflammatory arthritis population. Rheumatology (Oxford) 41: 176-179 [Abstract] [Full Text]  
• Girouard, J., Giguere, Y., Delage, R., Rousseau, F. (2002). Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients. Hum Mol Genet 11: 185-189 [Abstract] [Full Text]  
• Anderson, L.J., Holden, S., Davis, B., Prescott, E., Charrier, C.C., Bunce, N.H., Firmin, D.N., Wonke, B., Porter, J., Walker, J.M., Pennell, D.J. (2001). Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22: 2171-2179 [Abstract]  
• Beutler, E. (2001). Discrepancies between genotype and phenotype in hematology: an important frontier. Blood 98: 2597-2602 [Abstract] [Full Text]  
• Lyon, E., Frank, E. L. (2001). Hereditary Hemochromatosis Since Discovery of the HFE Gene. Clin. Chem. 47: 1147-1156 [Abstract] [Full Text]  
• Fargion, S., Valenti, L., Dongiovanni, P., Scaccabarozzi, A., Fracanzani, A. L., Taioli, E., Mattioli, M., Sampietro, M., Fiorelli, G. (2001). Tumor necrosis factor {alpha} promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 97: 3707-3712 [Abstract] [Full Text]  
• ADAMS, P C (2001). Iron overload in Montpelier. Gut 48: 755-756 [Full Text]  
• Aguilar-Martinez, P, Bismuth, M, Picot, M C, Thelcide, C, Pageaux, G-P, Blanc, F, Blanc, P, Schved, J-F, Larrey, D (2001). Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?. Gut 48: 836-842 [Abstract] [Full Text]  
• Steinberg, K. K., Cogswell, M. E., Chang, J. C., Caudill, S. P., McQuillan, G. M., Bowman, B. A., Grummer-Strawn, L. M., Sampson, E. J., Khoury, M. J., Gallagher, M. L. (2001). Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United States. JAMA 285: 2216-2222 [Abstract] [Full Text]  
• Fleming, R. E., Holden, C. C., Tomatsu, S., Waheed, A., Brunt, E. M., Britton, R. S., Bacon, B. R., Roopenian, D. C., Sly, W. S. (2001). Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 98: 2707-2711 [Abstract] [Full Text]  
• Rossi, E., Bulsara, M. K., Olynyk, J. K., Cullen, D. J., Summerville, L., Powell, L. W. (2001). Effect of Hemochromatosis Genotype and Lifestyle Factors on Iron and Red Cell Indices in a Community Population. Clin. Chem. 47: 202-208 [Abstract] [Full Text]  
• Brittenham, G. M., Klein, H. G., Kushner, J. P., Ajioka, R. S. (2001). Preserving the National Blood Supply. ASH Education Book 2001: 422-432 [Abstract] [Full Text]  
• Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., Seeff, L. B. (2000). Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring. Clin. Chem. 46: 2050-2068 [Abstract] [Full Text]  
• Rossi, E., McQuillan, B. M., Hung, J., Thompson, P. L., Kuek, C., Beilby, J. P. (2000). Serum Ferritin and C282Y Mutation of the Hemochromatosis Gene as Predictors of Asymptomatic Carotid Atherosclerosis in a Community Population. Stroke 31: 3015-3020 [Abstract] [Full Text]  
• Sham, R. L., Raubertas, R. F., Braggins, C., Cappuccio, J., Gallagher, M., Phatak, P. D. (2000). Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles. Blood 96: 3707-3711 [Abstract] [Full Text]  
• Bulaj, Z. J., Ajioka, R. S., Phillips, J. D., LaSalle, B. A., Jorde, L. B., Griffen, L. M., Edwards, C. Q., Kushner, J. P. (2000). Disease-Related Conditions in Relatives of Patients with Hemochromatosis. NEJM 343: 1529-1535 [Abstract] [Full Text]  
• Griffiths, W., Cox, T. (2000). Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism. Hum Mol Genet 9: 2377-2382 [Abstract] [Full Text]  
• Beutler, E., Felitti, V., Gelbart, T., Ho, N. (2000). The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic. ANN INTERN MED 133: 329-337 [Abstract] [Full Text]  
• Seamark, C. J, Hutchinson, M., Heath, I., McMullin, M F (2000). Controversy in primary care: Should asymptomatic haemochromatosis be treated? Treatment can be onerous for patient and doctor Commentary: False certainty of clinical guidance Commentary: Early treatment is essential. BMJ 320: 1314-1317 [Full Text]  
• ADAMS, P C (2000). Population screening for haemochromatosis. Gut 46: 301-303 [Full Text]  
• Bulaj, Z. J., Phillips, J. D., Ajioka, R. S., Franklin, M. R., Griffen, L. M., Guinee, D. J., Edwards, C. Q., Kushner, J. P. (2000). Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95: 1565-1571 [Abstract] [Full Text]  
• El-Serag, H. B., Inadomi, J. M., Kowdley, K. V. (2000). Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis. ANN INTERN MED 132: 261-269 [Abstract] [Full Text]  
• Rossi, E., Olynyk, J. K., Cullen, D. J., Papadopoulos, G., Bulsara, M., Summerville, L., Powell, L. W. (2000). Compound Heterozygous Hemochromatosis Genotype Predicts Increased Iron and Erythrocyte Indices in Women. Clin. Chem. 46: 162-166 [Abstract] [Full Text]  
• Franks, A. L., Burke, W. (2000). HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases. ANN INTERN MED 132: 246-246 [Full Text]  
• Brittenham, G. M., Weiss, G., Brissot, P., Laine, F., Guillygomarc'h, A., Guyader, D., Moirand, R., Deugnier, Y. (2000). Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism. ASH Education Book 2000: 39-50 [Abstract] [Full Text]  
• Andrews, N. C. (1999). Disorders of Iron Metabolism. NEJM 341: 1986-1995 [Full Text]  
• Tavill, A. S. (1999). Clinical Implications of the Hemochromatosis Gene. NEJM 341: 755-757 [Full Text]  
• Trinder, D., Olynyk, J. K., Sly, W. S., Morgan, E. H. (2002). Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc. Natl. Acad. Sci. USA 99: 5622-5626 [Abstract] [Full Text]  
• Sproule, T. J., Jazwinska, E. C., Britton, R. S., Bacon, B. R., Fleming, R. E., Sly, W. S., Roopenian, D. C. (2001). Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc. Natl. Acad. Sci. USA 98: 5170-5174 [Abstract] [Full Text]